These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11368823)

  • 1. Re-audit of antiretroviral prescribing in HIV patients.
    Hextall R; Monteiro EF
    Int J STD AIDS; 2001 Jun; 12(6):398-9. PubMed ID: 11368823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third regional audit of antiretroviral prescribing in HIV patients.
    Lee R; Monteiro EF;
    Int J STD AIDS; 2003 Jan; 14(1):58-60. PubMed ID: 12590796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audit of antiretroviral prescribing in HIV patients. Yorkshire Audit Group for HIV-related diseases.
    Monteiro E
    Int J STD AIDS; 1999 Oct; 10(10):692-3. PubMed ID: 10582642
    [No Abstract]   [Full Text] [Related]  

  • 4. British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve.
    Street E; Curtis H; Sabin CA; Monteiro EF; Johnson MA;
    HIV Med; 2009 Jul; 10(6):337-42. PubMed ID: 19490183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.
    Bassetti S; Battegay M; Furrer H; Rickenbach M; Flepp M; Kaiser L; Telenti A; Vernazza PL; Bernasconi E; Sudre P
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):114-9. PubMed ID: 10360802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An audit of antiretroviral medication offered to patients with HIV attending a district general hospital for outpatient care.
    Ivens D; Brook G
    Int J STD AIDS; 2000 Mar; 11(3):193-5. PubMed ID: 10726946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of early warning indicators of HIV resistance to antiretroviral (ARV) drugs in Ivory Coast in 2011].
    Yao KJ; Damey NF; Konan DJ; Aka J; Aka-Konan S; Ani A; Bonle MT; Kouassi D
    Pan Afr Med J; 2016; 25():52. PubMed ID: 28250876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When do HIV-infected persons start with antiretroviral therapy? A retrospective analysis of patients' monitoring and treatment status in general practice, as compared with the 1991 Dutch HIV treatment guidelines.
    Reedijk M; Wigersma L; Mohrs J
    Fam Pract; 1998 Dec; 15(6):525-8. PubMed ID: 10078791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tuberculous drug prescribing: doctors' compliance at a private teaching hospital in Pakistan.
    Khan JA; Hussain SF
    Trop Doct; 2003 Apr; 33(2):94-6. PubMed ID: 12680543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource-limited settings.
    Mtambo A; Chan K; Shen A; Lima V; Hogg R; Montaner J; Moore D
    HIV Med; 2012 Mar; 13(3):141-7. PubMed ID: 22107262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Findings from the British HIV Association's national clinical audit of first-line antiretroviral therapy and survey of treatment practice and maternity care, 2002.
    Brook MG; Curtis H; Johnson MA;
    HIV Med; 2004 Nov; 5(6):415-20. PubMed ID: 15544693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the 2011 UK post-exposure prophylaxis for HIV following sexual exposure guidelines: a regional retrospective audit.
    Bennett A; Wainwright E; Lord E; Oduru M; Chen F; Desmond N; Sherrard J; Duncan S
    Int J STD AIDS; 2015 Sep; 26(10):746-8. PubMed ID: 25332226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/AIDS treatment guidelines released.
    Randall P
    NIAID AIDS Agenda; 1997 Aug; ():1-2, 12. PubMed ID: 11364605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.
    Suárez-García I; González J; Berenguer J; García F; Portilla J; Muga R; Moreno S; Jarrín I;
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Nov; 37(9):580-587. PubMed ID: 30982676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of combination antiretroviral therapy in HIV-infected patients.
    Holtzer CD; Roland M
    Ann Pharmacother; 1999 Feb; 33(2):198-209. PubMed ID: 10084416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee.
    Lancet; 1997 Apr; 349(9058):1086-92. PubMed ID: 9107259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient adherence, not viral load now most important in HIV therapy.
    Rep Med Guidel Outcomes Res; 2000 Feb; 11(3):6-7. PubMed ID: 11768406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.